Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

Immunoassay Market Worth $46.49 Billion by 2028 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact

(, July 21, 2022 ) According to a new market research report “Immunoassay Market by Product & Solutions (Immunoassay Kits {ELISA, Rapid Tests}, Immunoassay Platform, Software & Services), Platform (Chemiluminescence, Radioimmunoassay), Application (Infectious Diseases, Oncology, Allergy), End User - Forecast to 2028”, published by Meticulous Research®, the immunoassay market is expected to grow at a CAGR of 7.5% from 2021 to reach $46.49 billion by 2028.

Download Free Sample Report Now @

Immunoassays are bioanalytical methods that use the specificity of an antigen-antibody reaction to detect and quantify target molecules in biological samples. These methods are frequently used in clinical diagnostics, drug discovery, drug monitoring, and food testing. Immunoassays have played a vital role in pharmaceutical analysis, such as diagnosis of diseases, therapeutic drug monitoring, clinical pharmacokinetics, and bioequivalence studies in drug discovery and pharmaceutical industries. The immunoassays industry is growing steadily due to various factors such as increased research and diagnosis for infectious disease testing as new pathogen strains develop each year. The market comprises kits & reagents, systems or analyzers, and software and services that can detect diseases or other conditions and can be used for research activities.

The immunoassay market is primarily segmented by product & solutions, platform, application, end user, and geography. The study also evaluates industry competitors and analyzes their market share at the global and regional level.

On the basis of product and solutions, the immunoassay kits and reagents segment accounted for the largest share of the overall immunoassay market in 2021. The largest share of this segment was mainly attributed to increasing number of immunoassay tests being performed globally, leading to recurrent purchases of kits and reagents, increasing focus on vaccine development to address challenges such as antimicrobial resistance and pandemics, and technological advancements in ELISpot assay kits. Furthermore, increase in demand for immunoassay based COVID-19 testing products along with cost-effectiveness of these products is likely to expand the growth of immunoassay kits and reagents segment in the upcoming years.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business:

On the basis of platform, the chemiluminescence immunoassays segment accounted for the largest share of the overall immunoassay market in 2021. Factors such as increasing adoption of chemiluminescence assays in clinical diagnostics, research applications, and pharmaceutical analysis due to low cost per test, and requirement of simple equipment, propel the segment growth.

On the basis of application, the infectious diseases segment accounted for the largest share of immunoassay market in 2021 owing to recent regulatory approvals for infectious disease screening products, product launches, rising incidence of infectious diseases, and an increase in the availability of COVID-19 test kits across the globe.

On the basis of end user, immunoassay market is broadly segmented into diagnostic reference laboratories, hospitals & clinics, research and academic laboratories, pharmaceutical and biotechnology companies, and other end users which comprises of nursing homes, ambulatory care centers, blood banks, and home healthcare agencies. In 2021, the diagnostic reference laboratories segment accounted for largest share of the overall immunoassay market. Rising level of laboratory automation, rise in the patient volume leading towards the rise in the number of tests being carried out in the diagnostic labs, availability of well-equipped immunoassay systems and skilled labor, growing prevalence of infectious diseases, and rising government initiatives are the factors supporting the largest share of diagnostic reference laboratories end user segment. However, the hospitals & clinics segment is expected to grow fastest during the forecast period due to the growing patient population, rising Medicare reimbursement for clinical tests performed in hospitals, and improving healthcare infrastructure.

Quick Buy – Immunoassay Market Research Report:

On the basis of geography, the global immunoassays market is mainly divided into five major regions, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the largest share which can be attributed to the rising prevalence of various infectious diseases, well-established healthcare sector, higher awareness regarding early disease diagnosis, increasing penetration of advanced medical devices, and increasing funding activities coupled with the development of novel advanced immunoassay solutions.

The report also includes extensive assessment of the product portfolio, geographic analysis, and key strategic developments adopted by leading market participants in the industry over the past 4 years. The immunoassay market has witnessed number of new product launches, approvals, agreements, collaborations, partnerships, & expansions in recent years. For instance, in April 2021, F. Hoffmann-La Roche AG (Switzerland) launched Elecsys Anti-p53 immunoassay for the detection of anti-p53 antibodies in cancer patients. The test is used in patients with bowel cancer, oesophageal cancer, and breast cancer. In September 2020, Siemens Healthineers AG (Germany) collaborated with Novartis Pharma AG (Switzerland), a pharmaceutical company, to support Novartis’s therapeutic pipeline by developing assays, primarily for serum neurofilament light chain (sNFL) immunoassay. The collaboration was also made to support Novartis’ MS and other neuroscience programs.

The key players operating in the global immunoassay market are F. Hoffman-La Roche AG (Switzerland), Abbott Laboratories (U.S.), Siemens AG (Germany), Danaher Corporation (U.S.), Sysmex Corporation (Japan), bioMérieux SA (France), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), and PerkinElmer, Inc. (U.S.) among others.

To gain more insights into the market with a detailed table of content and figures, click here:

Scope of the Report:

Immunoassay Market, by Product & Solutions

Immunoassay Kits and Reagents

Elisa Kits and Reagents

Rapid Test Kits and Reagents

Western Blot Kits and Reagents

ELISPOT Kits and Reagents

Other Immunoassay Kits and Reagents

Immunoassay Analyzers

Immunoassay Software and Services

Other immunoassay kits and reagents comprises of plasmon resonance-based immunoassays, radioimmunoassay, microfluidic assays, and nanomaterial and micro-material-based assays

Global Immunoassay Market, by Platform

Chemiluminescence Immunoassays

Fluorescence Immunoassays

Colorimetric Immunoassays


Other Immunoassay Platforms

Other immunoassay platforms comprise of turbidimetric immunoassays and counting immunoassays

Immunoassay Market, by Application

Infectious Diseases




Bone and Mineral Diseases

Autoimmune Diseases

Other Applications

Other applications comprise of toxicology, hematology, neonatal testing, allergy, and astrology

Immunoassay Market, by End Users

Diagnostics Reference Laboratories

Hospitals and Clinics

Research and Academic Laboratories

Pharmaceutical and Biotechnology Companies

Other End Users

Other end users comprise of nursing homes, ambulatory care centers, blood banks, and home healthcare agencies

Immunoassay Market, by Geography

North America









Rest of Europe (RoE)

Asia-Pacific (APAC)






Rest of APAC (RoAPAC)

Latin America



Rest of Latin America

Middle East & Africa

Download Free Sample Report Now @

Meticulous Research™


+91 744-7780008

Source: EmailWire.Com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.

GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | | i-Canada-News.Com | | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | | | | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | - Medicl Newswire and Press Release service of GroupWeb Media LLC